Edition:
United States

HTG Molecular amends, restates IVD test development, component supply agreement with Illumina


Monday, 5 Jun 2017 08:00am EDT 

June 5 (Reuters) - HTG Molecular Diagnostics Inc ::Amended and restated its IVD test development and component supply agreement with Illumina.HTG Molecular Diagnostics - agreement extends term, increases number of in-vitro diagnostic test kits that may be developed with Illumina sequencing technology.